Predictors of 1-year survival assessed at the time of bone marrow transplantation

Psychosomatics

Volumn 45, Issue 5, 2004, Pages 378-385

  Chang, Grace ^a   Orav, E John ^b   Tong, Mei Yee ^b   Antin, Joseph H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CIGARETTE SMOKING; COHORT ANALYSIS; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SURVIVAL; SURVIVAL RATE;

EID: 4444279143     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.45.5.378     Document Type: Article

References (45)

1. Lee SJ: Chronic myelogenous leukemia. Br J Haematol 2000; 111:993-1009
2. Singer C, Stark G, O'Brien SG: An update on chronic myeloid leukemia. Clin Med 2001; 1:354-357
3. Gaziev D, Galimberti M, Polchi P, Angelucci E, Giardini C, Baronciani D, Andreani M, Persisni B, Erer B, Sodani P, Manna M, Nicolini G, Visani G, Lucarelli G: Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results. Bone Marrow Transplant 2002; 29:1-8
4. Goldman JM, Melo JV: Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344:1084-1086
5. Druker BJ, Talpax M, Resta DJ, Peng B, Buchdunger D, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL: Efficacy and safety of a specific inhibitor of BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344:1031-1037
6. Druker BJ, Sawyers CL, Kantjarian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344:1038-1042
7. Silberman G, Crosse MG, Peterson EA, Weston RC, Horowitz MM, Appelbaum R, Chesson RD: Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med 1994; 331:1063-1067
8. Negrin RS: Bone marrow transplantation in chronic myelogenous leukemia. http://uptodateonline.com (accessed 9/22/2000)
9. Savage DG, Szydlo RM, Chase A, Apperley JF, Goldman JM: Bone marrow transplantation for chronic myeloid leukemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol 1997; 99:30-35
10. Enright H, Daniels K, Arthur DC, Dusenbery KE, Kersey JH, Kim T, Miller WJ, Ramsay NKC, Vercellotti GM, Weisdorf DJ, McGlave PB: Related donor marrow transplant for chronic myeloid leukemia: patient factors predictive of outcome. Bone Marrow Transplant 1996; 17:537-542
11. Lee SJ, Kuntz K, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH: Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann Intern Med 1997; 127:1080-1088
12. Pigneux A, Tanguy ML, Michallet M, Jouet JP, Kuentz M, Vernant JP, Milpied N, Ifrah N, Cahan JY, Gratecos N, Reman O, Cure H, Caillot D, Witz F, Pillier-Loriette C, Tron P, Reiffers J: Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukemia. Br J Haematol 2002; 116:193-201
13. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338:962-968
14. Reiter E, Greinix HT, Keil F, Brugger S, Rabitsch W, Schulenburg A, Mannhalter C, Schwarzinger L, Worel N, Volc-Platzer B, Fischer G, Dieckmann K, Hinterberger W, Schneider B, Haas OA, Geissler K, Kalhs P: Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia. Ann Hematol 1999; 78:507-513
15. Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ: Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med 2001; 110:339-346
16. Hoodin F, Weber S: A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 2003; 44:181-195
17. Colon EA, Callies AL, Popkin ML, McGlave PB: Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 1993; 34:420-425
18. Andrykowski MA, Brady MJ, Henslee-Downey PJ: Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 1994; 56:432-439
19. Broers S, Hengeveld MW, Kaptein AA, LeCessie S, van de Loos F, deVries T: Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J Psychosom Res 1998; 45:341-351
20. DiMartini A, Weinrieb R, Fireman M: Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am 2002; 25:195-209
21. Menon KV, Narayanan MD, Gores GJ, Shah VH: Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clinic Proceedings 2001; 76:1021-1029
22. Howard L, Fahy T: Liver transplantation for alcoholic liver disease. Br J Psychiatry 1999; 171:497-500
23. Pageaux GP, Michel J, Coste V, Perney P, Possoz P, Perrigault PF, Navarro F, Fabre JM, Domergue J, Blanc P, Larrey D: Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999; 45:421-426
24. Chang G, Antin JH, Orav EJ, Randall U, McGarigle C, Behr H: Substance abuse and bone marrow transplant. Am J Drug Alcohol Abuse 1997; 23:301-308
25. Schipper H, Clinch J, McMurray A, Levitt M: Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncology 1984; 2:472-483
26. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Sheperd R, Battista RN, Catchlove BR: Measuring the quality of life of cancer patients. J Chronic Dis 1985; 34:585-597
27. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979
28. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
29. Sobell LC, Sobell MC: Timeline Followback: a technique for assessing self-reported ethanol consumption, in Techniques to Assess Alcohol Consumption. Edited by Allen J, Litten R. New Jersey, Humana Press, 1992
30. Treiman DJ: Occupational Prestige in Comparative Perspective. New York, Academic Press, 1977
31. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA: Causes of death in autopsied liver transplantation patients. Modern Pathology 1998; 11:37-46
32. Sundberg ND: Review of the Beck Depression Inventory, in The Eleventh Mental Measurements Yearbook [Revised Edition]. Edited by Kramer JJ, Conoley JC. Lincoln, University of Nebraska Press, 1992, pp 79-81
33. US Department of Health and Human Services: Reducing tobacco use: a report of the Surgeon General. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, 2000
34. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime co-occurrence of DSM-II-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Psychiatry 1997; 54:313-321
35. Tonnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hague C, Pedersen IK, Kehlet H: Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised control trial. Br Med J 1999; 318:1311-1316
36. Doll R: Cancers weakly related to smoking. Br Med Bull 1996; 52:35-49
37. Severson RK: Does cigarette smoking lead to the subsequent development of leukemia? Arch Intern Med 1993; 153:425-427
38. Brownson RC, Novotny TE, Perry MC: Cigarette smoking and adult leukemia. Arch Intern Med 1993; 153:469-475
39. Stagnaro E, Rammazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Neri M, Rodella S, Costantini AS, Tumino R, Vignano C, Vindigni C, Vineis P: Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12:325-334
40. Adami J, Nyren O, Bergstrom R, Ekbom A, Engholm G, Englund A, Glimelius B: Smoking and the risk of leukemia, lymphoma, and multiple myleoma (Sweden). Cancer Causes Control 1998; 9:49-56
41. US Department of Health and Human Services: Tenth Special Report to the US Congress on Alcohol and Health
42. Lundberg JC, Passik SD: Alcohol and cancer: a review for psychooncologists. Psycho-oncology 1997; 6:253-266
43. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE: The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996; 275:50-54
44. Babor TF, Steinberg K, Anton R, DelBoca F: Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol 2000; 61:55-63
45. Council on Ethical and Judicial Affairs, American Medical Association: Ethical demand for liver transplantation. Clin Transplant 1997; 11:49-55